|国家预印本平台
首页|炎症反应在心梗后心衰发病过程中的作用研究进展

炎症反应在心梗后心衰发病过程中的作用研究进展

中文摘要英文摘要

心梗后心衰是慢性心力衰竭中最常见的类型,近年研究发现炎症反应迅速、持续的激活是心梗后心衰的重要特征。适当的炎症反应可以减少心肌梗死范围,促进瘢痕形成及缺血心肌的恢复,而炎症反应过度、持久激活可促进心脏扩大、心功能不全及心力衰竭。心肌梗死后心肌细胞释放坏死物质,通过激活TLR介导的通路、补体系统以及ROS诱导的通路调控NF-κB相关通路,激活体内固有免疫。同时中性粒细胞、单核细胞、巨噬细胞等多种细胞参与了炎症过程。如何通过调控心梗后心衰过程中的炎症反应从而抑制病理性重构为心衰的治疗提供了新的方向。本文从炎症反应激活过程中的细胞基础及相关通路两方面,对炎症反应在心梗后心衰过程中的作用及机制做一系统综述,为进一步研究心衰过程中炎症反应的作用及抗炎治疗提供参考。

Myocardial infarction is the most common cause that induces heart failure. Recent studies have identified thatinstant and prolonged activation of inflammatory response is a key character of post-infarction heart failure. Inflammatoryresponse to some degree can promote wound healing, scar formation and recovery of ischemic myocardium, but excessiveinflammation could play an important role in the development of chamber dilation, systolic dysfunction and heart failure.Extensive necrosis in the infarcted myocardium triggers the innate immune response through stimulating Toll-Like Receptor(TLR) mediated signaling, activating the complement cascade and reactive oxygen species (ROS) pathway, and regulating theNuclear Factor (NF)- B system. Neutrophils, mononuclear cells, macrophages and other kinds of cells play essential roles ininflammation. How to control inflammation to suppress pathological remodeling is an important issue to be considered indeveloping new treatment for heart failure. This review summarizes the roles of related cells and signal pathways in thepathophysiological mechanisms of inflammation in myocardial induced heart failure in order to provide references for furtherstudy in the effects of inflammation and anti-inflammatory therapies in heart failure.

刘雪岩;李成花;杨 萍

10.12074/201712.00451V1

内科学基础医学临床医学

心力衰竭炎症反应心肌梗死免疫

刘雪岩;李成花;杨 萍.炎症反应在心梗后心衰发病过程中的作用研究进展[EB/OL].(2017-12-07)[2025-08-04].https://chinaxiv.org/abs/201712.00451.点此复制

评论